The GLP-1 Rebound: New Evidence Quantifies Weight Regain After Treatment Cessation
A 2026 eClinicalMedicine study reveals that stopping GLP-1 drugs like Ozempic and Wegovy leads to rapid weight regain, plateauing at 75% according to modeling.
By: AXL Media
Published: Mar 17, 2026, 12:17 PM EDT
Source: GMA
Modeling the Long-Term Trajectory
While the one-year data is based on empirical follow-up, the researchers utilized nonlinear meta-regression to predict what happens beyond the first year. The model suggests that the rapid initial regain eventually begins to slow and plateau.
1-Year Regain: ~60% of total weight lost.
Projected Plateau: ~75% of total weight lost (estimated to stabilize around week 60).
Net Retention: Patients are projected to keep off roughly 25% of their initial loss long-term, which researchers noted still offers a "clinically meaningful" benefit of roughly 4% to 5% of their baseline weight.
The "Brake" Analogy: Why the Weight Returns
Categories
Topics
Related Coverage
- Global Vertical Race China and United States Lead 2026 Skyscraper Rankings
- Foreign Gold Miners in Mali Boost Private Security Spending to Sustain Operations Amid Rising Conflict
- New Seraph Evangelical Ministries Demands Proactive National Security Reforms Amidst Major Conference Unveil
- Saudi Arabia Moves to Execute 65 Ethiopian Migrants Following Disputed Drug Related Convictions